This inventor holds 1 USPTO granted patent. Top assignees: Fundación Del Sector Público Estatal Centro Nacional De Investigaciones Oncologicas Carlos III (f.s.p. Cnio), Universität Autonoma De Barcelona. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2022
Title: Innovations by Bruno Bernardes De Jesus
Introduction
Bruno Bernardes De Jesus is a notable inventor based in Madrid, Spain. He has made significant contributions to the field of medical research, particularly in therapies related to myocardial infarction. His innovative work has the potential to impact the treatment and prevention of serious health conditions.
Latest Patents
Bruno Bernardes De Jesus holds a patent for "Telomerase reverse transcriptase-based therapies for treatment of conditions associated with myocardial infarction." This invention provides compositions and methods that are useful for treating and preventing conditions linked to myocardial infarction. He has 1 patent to his name, showcasing his commitment to advancing medical science.
Career Highlights
Throughout his career, Bruno has worked with esteemed institutions such as the Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III and the Universitat Autònoma de Barcelona. His experience in these organizations has allowed him to collaborate with leading experts in the field.
Collaborations
Bruno has had the opportunity to work alongside notable colleagues, including Maria Antonia Blasco Marhuenda and Christian Baer. These collaborations have enriched his research and contributed to the development of innovative therapies.
Conclusion
Bruno Bernardes De Jesus is a distinguished inventor whose work in telomerase reverse transcriptase-based therapies holds promise for improving health outcomes related to myocardial infarction. His contributions to medical research are noteworthy and reflect his dedication to innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile